Neurosense Therapeutics is trading 13.1% up at $0.43, with the move appearing primarily supported by biotechnology-sector strength.
- XBI is up 2.06% during the regular session.
- A special shareholder meeting is scheduled for August 26, 2026, to vote on potential 1-for-4 to 1-for-40 reverse share splits.
- No confirmed company-specific announcement explains the intraday gain; the meeting adds event-related attention.